UKRI COVID grant extensions — formally the UKRI COVID-19 Grant Extension Allocation (CoA) — were a costed, time-boxed funding mechanism used between 2020 and 2021 to extend research and fellowship awards disrupted by the pandemic. Although the scheme closed to new applications years ago, its expenditure still falls inside institutional audit cycles, because UKRI’s funding assurance reviews and grant-condition checks operate on multi-year lookback windows, not calendar-year cut-offs.
The CoA is defined by UKRI as a supplementary, costed award — distinct from an ordinary no-cost extension — issued to sustain UKRI grant-funded research and fellowships affected by the pandemic, subject to its own terms, conditions and reporting deadlines.
- What was the UKRI COVID-19 Grant Extension Allocation (CoA)?
- Why UKRI COVID grant extensions still surface in institutional audits
- CoA vs a standard no-cost extension: what changed under UKRI grant conditions
- What documentation satisfies auditors reviewing CoA-funded extensions
- Frequently asked questions
What was the UKRI COVID-19 Grant Extension Allocation (CoA)?
The CoA ran from 2020 into 2021 as UKRI’s principal response to pandemic-related disruption of active grants. UKRI’s own FAQ describes its aim as providing “UK organisations with resources to sustain UKRI grant-funded research and fellowships affected by” the pandemic. Unlike a routine no-cost extension, which extends time only, the CoA was a genuine additional award: UKRI’s terms and conditions state plainly that “extensions of CoA can only be offered in specific circumstances and will be supported through an additional award.”
A related, narrower scheme targeted doctoral students specifically. In February 2021, a written ministerial statement to Parliament confirmed £44 million of urgent funding for up to six-month extensions for PhD students in their final year unable to complete their studies. UKRI later reported a further £19 million committed under the Doctoral Extensions Policy Phase 2 Awards, published in a full report dated February 2025, covering students who could not mitigate pandemic delays through the initial phase of support.
Both strands closed to new applications once their windows lapsed, but institutions that drew on either allocation retained reporting obligations — a Final Report and a Final Expenditure Statement — that created the audit trail now being revisited.
Why UKRI COVID grant extensions still surface in institutional audits
Institutional audits and UKRI funding-assurance reviews do not treat 2020-21 expenditure as closed simply because the pandemic has receded. Grant conditions require institutions to retain records for a defined period after a grant’s Final Expenditure Statement, and CoA-funded costs sit inside exactly the same retention and eligibility rules as any other award expenditure.
Three forces keep the CoA in scope for auditors in 2026:
- Retention windows outlast the news cycle. Record-retention obligations attached to a grant run from the Final Expenditure Statement date, not from the original award date — so CoA awards accepted late in the scheme can still be inside their retention period.
- Funding assurance reviews are cyclical, not one-off. UKRI’s assurance activity revisits institutional financial control on a rolling basis, which means expenditure from 2020-21 can legitimately fall inside a review conducted years later.
- The CoA was a bespoke instrument, so its rules are easy to misapply. Because the CoA was a costed additional award rather than a standard no-cost extension, staff costs, equipment, and consumables charged against it must be tested against the CoA-specific terms and conditions — not the general no-cost-extension rules that apply to most current requests. Institutional audit teams that apply the wrong rule set are the most common source of a finding.
CoA vs a standard no-cost extension: what changed under UKRI grant conditions
The distinction between the CoA and today’s ordinary no-cost extension is the single most consequential fact for an audit reviewing pandemic-era files, and it is easy to lose years after the event.
| Feature | UKRI COVID-19 Grant Extension Allocation (CoA) | Standard no-cost extension (current UKRI grant conditions) |
|---|---|---|
| Funding basis | Costed — supported through an additional award | No additional cost; time only |
| Maximum duration | Case-by-case, tied to pandemic disruption | Up to 6 months over the grant’s lifetime for non-people-related reasons; up to the actual delay for people-related reasons (per UKRI guidance updated 7 May 2026) |
| Application status | Closed since 2021 | Open, ongoing route via the grant’s award system |
| Reporting obligation | Final Report plus Final Expenditure Statement, due by end of 2021 | Standard Final Expenditure Statement at the (extended) grant end date |
UKRI’s current guidance on requesting a change to a project confirms the modern no-cost-extension rule directly: “no-cost extensions due to non-people related reasons may not exceed six months over the lifetime of the grant, unless exceptions apply.” Extensions justified by people-related reasons — parental leave, sick leave, recruitment delay — may instead run for the actual length of the delay. Neither rule was designed with the CoA’s bespoke, costed structure in mind, which is exactly why an auditor applying today’s no-cost-extension test to a 2020-21 CoA award will misclassify the expenditure.
What documentation satisfies auditors reviewing CoA-funded extensions
Research offices preparing for a funding-assurance visit or an institutional audit that touches pandemic-era grants should be able to produce, for each CoA award:
- The original CoA award letter or additional-award confirmation, showing it was issued as a costed extension rather than a no-cost one.
- The stated justification for the extension, tied to a specific pandemic-related circumstance rather than a general reference to COVID-19.
- Timesheets or equivalent evidence for any staff costs charged against the additional award.
- The Final Report and Final Expenditure Statement submitted at scheme close, plus any correspondence extending those deadlines.
- A clear cross-reference showing which grant conditions — CoA-specific or standard — governed each cost line, so a reviewer does not default to the wrong rule set.
Where a doctoral extension was funded under the separate £44 million or £19 million allocations described above, the same principle applies: keep the scheme-specific approval letter alongside the standard studentship file, because the eligibility criteria for those cohorts differ from both the CoA and the ordinary no-cost extension.
Frequently asked questions
What is the UKRI COVID-19 Grant Extension Allocation (CoA)?
The CoA was a costed, additional UKRI award — not a standard no-cost extension — issued between 2020 and 2021 to sustain grant-funded research and fellowships disrupted by the pandemic. It closed to new applications once its funding window ended, but its terms still govern how that historic expenditure must be assessed in an audit.
How long can a UKRI no-cost extension run under current grant conditions?
Under UKRI guidance current as of May 2026, a no-cost extension for non-people-related reasons may not exceed six months over the lifetime of the grant, unless exceptions apply. Extensions justified by people-related reasons, such as parental or sick leave, may instead run for the length of the actual delay.
Why do auditors still ask about COVID-era grant extensions?
Grant record-retention obligations run from the Final Expenditure Statement date, and UKRI’s funding-assurance reviews revisit institutional financial control on a rolling cycle. Both mean CoA-funded expenditure from 2020-21 can still fall legitimately inside a current review, especially where cost lines were charged under bespoke, non-standard terms.
Can an institution still apply for a new CoA extension today?
No. The CoA closed to new applications once its funding window lapsed in 2021. Institutions cannot open new CoA claims; the only live task is ensuring historic CoA expenditure and its supporting evidence remain correctly documented against the scheme’s original, costed terms.
For research offices, the practical implication is straightforward: pandemic-era grant files are not a closed chapter simply because the news cycle has moved on. Institutions that keep the CoA’s costed, bespoke terms clearly separated from today’s standard no-cost-extension rules — and can point an auditor to the correct rule set for each historic cost line — are the ones that clear a funding-assurance review without a finding. That discipline, more than any single retained document, is what the legacy of the CoA now demands of institutional grant administration.
Research offices building broader institutional compliance capability may also find it useful to review general research administration practice alongside funder-specific rules such as these.